Senior Commercial Product Manager, NGS
Danaher Corporation
Summary
The Senior Commercial Product Manager, NGS is responsible for driving commercial strategy and sustainable growth in the NGS portfolio. This team member will need to collaborate cross-functionally with Sales, Marketing and the innovation Product team to plan to drive revenue and margin growth in alignment with long-term business objectives. You will serve as the commercial subject matter expert and product champion, both internally and externally, by analyzing customer feedback, market trends, competitive dynamics, sales performance, and regulatory requirements. This role will require management of the full product lifecycle, from new product launches to obsolescence, ensuring alignment with product strategy.
Job description
In this role, you will have the opportunity to:
- Develop an annual strategic plan to achieve product revenue and margin growth objectives and drive actions that lead to sustainable growth and the completion of strategic objectives
- Serve as a commercial subject matter expert and product champion internally and externally, including regularly analyzing and communicating and managing response to customer feedback, market trends, competitor performance, sales channels, and regulatory requirements
- Manage all aspects of product life cycle, including new product launch and execution of obsolescence to meet product strategy
- Partner with Sales and Marketing teams to develop effective positioning strategies, marketing campaigns, collateral, sales and support tools, and training programs to drive growth
- Partner with Quality Assurance and Operations on supply issues and own communications for commercial teams and customers when necessary
The essential requirements of the job include:
- Bachelor's degree with 5+ years experience in biological sciences (biology, chemistry, biochemistry)
- 3 years (min.) of experience in Next Generation Sequencing product management, strategic marketing or commercial experience or other relevant technical environment
- Willingness and ability to travel approximately 20% domestically and internationally
- 2+ years of experience in high-touchpoint customer facing roles
- Demonstrated success developing portfolio strategies, commercial growth plans, product positioning, and go-to-market programs
It would be a plus if you also possess:
- PhD in biological sciences (biology, chemistry, biochemistry) or a related field
- Demonstrated understanding of competitors, technologies, trends, and key challenges in NGS, Pharma, Clinical and Oncology research markets
- 5+ years in the biotechnology, genomics, next-generation sequencing (NGS) industry, or other relevant technical environment
Requirements
- Bachelor's degree with 5+ years experience in biological sciences (biology, chemistry, biochemistry)
- 3 years (min.) of experience in Next Generation Sequencing product management, strategic marketing or commercial experience or other relevant technical environment
- Willingness and ability to travel approximately 20% domestically and internationally
- 2+ years of experience in high-touchpoint customer facing roles
- Demonstrated success developing portfolio strategies, commercial growth plans, product positioning, and go-to-market programs
- PhD in biological sciences (biology, chemistry, biochemistry) or a related field
- Demonstrated understanding of competitors, technologies, trends, and key challenges in NGS, Pharma, Clinical and Oncology research markets
- 5+ years in the biotechnology, genomics, next-generation sequencing (NGS) industry, or other relevant technical environment
Benefits
- Health care program
- Paid time off
- Medical insurance
- Dental insurance
- Vision insurance
- 401(k)
- Bonus/incentive pay
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.